Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Minerva Urologica e Nefrologica 2019 August;71(4) > Minerva Urologica e Nefrologica 2019 August;71(4):359-64

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

REVIEW   Free accessfree

Minerva Urologica e Nefrologica 2019 August;71(4):359-64

DOI: 10.23736/S0393-2249.19.03315-0

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Testis-sparing surgery for testicular masses: current perspectives

Roberto LA ROCCA 1, Marco CAPECE 1 , Lorenzo SPIRITO 1, Marcus K. CUMBERBATCH 2, Massimiliano CRETA 1, Vincenzo ALTIERI 3, Giorgio FRANCO 4, Simone ALBISINNI 5, Vincenzo MIRONE 1, Francesco ESPERTO 5, on behalf of EAU-ESRU (European Associations of Urology-European Society of Residents Urologist)

1 Department of Urology, Federico II University, Naples, Italy; 2 Unit of Academic Urology, Department of Urology, University of Sheffield, Sheffield, UK; 3 Department of Urology, Humanitas Gavazzeni Hospital, Bergamo, Italy; 4 Department of Urology, Sapienza University, Rome, Italy; 5 Department of Urology, University Clinics of Brussels, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium



INTRODUCTION: Males who present with a palpable testis nodule are likely to have malignant germ cell tumor in >90% of cases. Therefore radical orchiectomy remains the standard of care for intratesticular tumors. However, due to the recent developments of high-frequency probes in ultrasonography, the incidence of detecting a small non-palpable testis tumor is higher and higher. These lesions are thought to be benign in more than 60-80% of cases, thus a radical orchiectomy should be considered an overtreatment. In addition to that, radical orchiectomy might cause infertility, psychological issues and endocrine disorders, hence an organ-sparing procedure in such cases should be pursued.
EVIDENCE ACQUISITION: Only fourteen reliable retrospective studies met the inclusion criteria. No prospective randomized trials have appeared in Medline database.
EVIDENCE SYNTHESIS: This review of the current literature has confirmed the safety and efficacy of testicular-sparing surgery in selected patients: 1) monorchid patients; 2) bilateral testis masses; 3) normal patients with a small, non-palpable masses detected with US, as long as the dimension of the lesion is up to 3 cm and not greater that 30% of the total volume of the organ.
CONCLUSIONS: According to the literature, testis sparing surgery is a safe and feasible procedure for patients presenting a benign small testis mass. The enthusiasm found in the literature should however be tempered as the small number of patients reported in the studies coupled with the absence of a prospective trial represent important limits that need to be overtaken. Therefore more robust and well-designed studies are needed.


KEY WORDS: Orchiectomy; Testicular neoplasms; Review

inizio pagina